We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$41.7M
AUM Growth
+$8.11M
Cap. Flow
+$6.96M
Cap. Flow %
16.67%
Top 10 Hldgs %
89.74%
Holding
33
New
9
Increased
3
Reduced
4
Closed
8

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$9.33M
2
CMA
Comerica
CMA
+$323K
3
IVZ icon
Invesco
IVZ
+$202K
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$160K
5
VDE icon
Vanguard Energy ETF
VDE
+$135K

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.13M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$487K
3
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
+$428K
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$304K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$283K

Sector Composition

Rank Sector Weight
1 Technology 31.22%
2 Energy 16.24%
3 Healthcare 16.1%
4 Materials 2.63%
5 Financials 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
1
Texas Instruments
TXN
$253B
$13M 31.22%
145,400
+113,400
+354% +$9.33M
WPZ
2
DELISTED
Williams Partners L.P.
WPZ
$6.72M 16.09%
172,732
– –
VEA icon
3
Vanguard FTSE Developed Markets ETF
VEA
$238B
$3.27M 7.84%
75,430
-7,162
-9% -$304K
VOO icon
4
Vanguard S&P 500 ETF
VOO
$1.03T
$2.87M 6.88%
12,446
-1,249
-9% -$283K
VOE icon
5
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$2.87M 6.87%
27,165
-2,007
-7% -$209K
SYRE icon
6
Spyre Therapeutics
SYRE
$9.18B
$2.59M 6.2%
20,997
– –
VWO icon
7
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$2.53M 6.06%
58,049
-6,280
-10% -$272K
BPTH
8
DELISTED
Bio-Path Holdings Inc
BPTH
$1.38M 3.3%
958
– –
VDE icon
9
Vanguard Energy ETF
VDE
$10.4B
$1.1M 2.64%
11,781
+1,521
+15% +$135K
GMO
10
DELISTED
General Moly, Inc.
GMO
$1.1M 2.63%
2,922,831
– –
VRDN icon
11
Viridian Therapeutics
VRDN
$2.59B
$965K 2.31%
7,031
– –
VNQ icon
12
Vanguard Real Estate ETF
VNQ
$38.6B
$829K 1.99%
9,978
+789
+9% +$65.9K
APEN
13
DELISTED
Apollo Endosurgery, Inc.
APEN
$722K 1.73%
154,301
– –
LXRX icon
14
Lexicon Pharmaceuticals
LXRX
$1.05B
$439K 1.05%
35,714
– –
PLXP
15
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$403K 0.97%
62,673
– –
CMA
16
DELISTED
Comerica
CMA
$343K 0.82%
+4,510
New +$323K
IVZ icon
17
Invesco
IVZ
$13.9B
$207K 0.5%
+5,900
New +$202K
RETA
18
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$166K 0.4%
+5,322
New +$160K
KYNB
19
Kyntra Bio
KYNB
$28.7M
$61K 0.15%
+45
New +$47.4K
INSW icon
20
International Seaways
INSW
$4.58B
$59K 0.14%
+3,000
New +$61.3K
CIM
21
Chimera Investment
CIM
$991M
$57K 0.14%
+1,000
New +$56.8K
IWP icon
22
iShares Russell Mid-Cap Growth ETF
IWP
$21B
$25K 0.06%
+448
New +$24.6K
POR icon
23
Portland General Electric
POR
$5.74B
$5K 0.01%
118
– –
BA icon
24
Boeing
BA
$183B
$2K ﹤0.01%
+6
New +$1.4K
PEP icon
25
PepsiCo
PEP
$189B
$2K ﹤0.01%
+20
New +$2.31K
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2017 Portfolio in Review

As of Q3 2017, University of Texas/Texas AM Investment Management Co (UTIMCO) held 33 positions worth $41.7M, up 24% from $33.6M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $6.96M of net new capital in Q3 2017, opening 9 new positions and adding to 3 existing holdings. Its largest new stake was Comerica: 4,510 shares worth $343K.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 7.3% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $304K trimmed.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2017 buy was Comerica: 4,510 shares worth $343K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Texas Instruments in Q3 2017, an estimated $9.33M increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q3 2017 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $304K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited ExxonMobil in Q3 2017, selling an estimated $1.13M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 90% of its $41.7M portfolio in Q3 2017.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 9 new positions and closed 8 in Q3 2017.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 24% quarter-over-quarter to $41.7M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2017, filed 13 Nov 2017.